Vaccination strategies for Korean patients with inflammatory bowel disease
Open Access
- 8 August 2022
- journal article
- review article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 37 (5), 920-930
- https://doi.org/10.3904/kjim.2022.149
Abstract
Patients with inflammatory bowel disease (IBD) are vulnerable to vaccine- preventable infectious diseases. Immunosuppressive drugs, which are often used to manage IBD, may increase this vulnerability and attenuate vaccine efficacy. Thus, healthcare providers should understand infectious diseases and schedule vaccinations for them to reduce the infection-related burden of patients with IBD. All patients with IBD should be assessed in terms of immunity to vaccine-preventable diseases at the time of IBD diagnosis, and be vaccinated appropriately. Vaccination is becoming more important because of the unprecedented coronavirus disease 2019 (COVID-19) global health crisis. This review focuses on recent updates to vaccination strategies for Korean patients with IBD.Funding Information
- Keimyung University Dongsan Medical Center
This publication has 80 references indexed in Scilit:
- Prevalence of Hepatitis-B Viral Markers in Patients With Inflammatory Bowel Disease in a Hepatitis-B-Endemic AreaJournal of Clinical Gastroenterology, 2014
- Immunization Rates and Vaccine Beliefs Among Patients with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2014
- Immunogenicity and Tolerability to Human Papillomavirus-like Particle Vaccine in Girls and Young Women with Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2013
- Increased Risk of Pneumonia Among Patients With Inflammatory Bowel DiseaseThe American Journal of Gastroenterology, 2013
- Increased risk of herpes zoster among 108 604 patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2012
- Varicella zoster virus infection in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Normal Response to Vaccines in Inflammatory Bowel Disease Patients Treated with ThiopurinesInflammatory Bowel Diseases, 2012
- Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapyGut, 2010
- Eficacia de la vacuna contra el virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinalMedicina Clinica, 2009
- Vaccine adjuvants: Current state and future trendsImmunology & Cell Biology, 2004